Cutaneous Melanoma Detection and Management

Cutaneous melanoma arises from pigment-producing cells in the skin and, while less common than other skin cancers, accounts for the large majority of skin cancer deaths because of its tendency to metastasize early. Accurate diagnosis has historically depended on expert visual inspection with dermoscopy, but deep learning systems trained on large image datasets are now approaching or matching dermatologist performance, raising practical questions about how to integrate these tools reliably into clinical workflows. Once melanoma spreads, sentinel lymph node biopsy helps map disease extent and guide treatment decisions, while advances in immunotherapy and targeted agents directed at specific genetic alterations — particularly in the BRAF pathway — have substantially improved survival for patients with advanced-stage disease. Active research continues to refine tumor staging criteria, identify biomarkers that predict treatment response, and understand the epidemiological drivers behind rising incidence rates across many populations.

Works

101,575

Total citations

1,255,646

Keywords

MelanomaDermoscopySkin CancerSentinel Lymph Node BiopsyGenetic AlterationsImmunotherapy